Company Filing History:
Years Active: 2025
Title: Byoung Joon Ko: Innovator in Monoclonal Antibody Development
Introduction
Byoung Joon Ko is a prominent inventor based in Chungcheongbuk-do, South Korea. He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic agents targeting specific receptors.
Latest Patents
Ko holds a patent for an "Endothelin receptor type A activity regulating antibody." This invention relates to a monoclonal antibody or a fragment that specifically recognizes and binds to the extracellular domain of the endothelin receptor type A. The monoclonal antibody is designed for use as a therapeutic agent for conditions such as hypertension or cancer associated with endothelin receptor type A. He has 1 patent to his name.
Career Highlights
Byoung Joon Ko is currently associated with Hedgehog, Inc., where he continues to advance his research and development efforts. His work focuses on innovative solutions in the medical field, particularly in the treatment of serious health conditions.
Collaborations
Ko collaborates with notable colleagues, including Sang Taek Jung and Yeon Gyu Yu, who contribute to his research initiatives and projects.
Conclusion
Byoung Joon Ko is a dedicated inventor whose work in monoclonal antibodies holds promise for therapeutic advancements in treating hypertension and cancer. His contributions to biotechnology are noteworthy and continue to impact the field positively.